Positive Regulation of Interleukin-1β Bioactivity by Physiological ROS-Mediated Cysteine S-Glutathionylation.
Xue Zhang,Peng Liu,Christie Zhang,Direkrit Chiewchengchol,Fan Zhao,Hongbo Yu,Jingyu Li,Hiroto Kambara,Kate Y Luo,Arvind Venkataraman,Ziling Zhou,Weidong Zhou,Haiyan Zhu,Li Zhao,Jiro Sakai,Yuanyuan Chen,Ye-Shih Ho,Besnik Bajrami,Bing Xu,Leslie E Silberstein,Tao Cheng,Yuanfu Xu,Yuehai Ke,Hongbo R Luo
DOI: https://doi.org/10.1016/j.celrep.2017.05.070
IF: 8.8
2017-01-01
Cell Reports
Abstract:Reactive oxygen species (ROS)-induced cysteine S-glutathionylation is an important posttranslational modification (PTM) that controls a wide range of intracellular protein activities. However, whether physiological ROS can modulate the function of extracellular components via S-glutathionylation is unknown. Using a screening approach, we identified ROS-mediated cysteine S-glutathionylation on several extracellular cytokines. Glutathionylation of the highly conserved Cys-188 in IL-1β positively regulates its bioactivity by preventing its ROS-induced irreversible oxidation, including sulfinic acid and sulfonic acid formation. We show this mechanism protects IL-1β from deactivation by ROS in an in vivo system of irradiation-induced bone marrow (BM) injury. Glutaredoxin 1 (Grx1), an enzyme that catalyzes deglutathionylation, was present and active in the extracellular space in serum and the BM, physiologically regulating IL-1β glutathionylation and bioactivity. Collectively, we identify cysteine S-glutathionylation as a cytokine regulatory mechanism that could be a therapeutic target in the treatment of various infectious and inflammatory diseases.